Glucocorticoid Receptor Signaling Impairs Protein Turnover Regulation in Hypoxia-Induced Muscle Atrophy in Male Mice
暂无分享,去创建一个
W. Lamers | A. Schols | C. de Theije | R. Langen | J. Hermans | R. V. van Gorp | S. E. Köhler | J. J. Ceelen | S. Köhler | Rick H. van Gorp
[1] Sangeeta Khare,et al. Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition) , 2016 .
[2] A. Goldberg,et al. Regulation of autophagy and the ubiquitin–proteasome system by the FoxO transcriptional network during muscle atrophy , 2015, Nature Communications.
[3] F. Britto,et al. REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy. , 2014, American journal of physiology. Endocrinology and metabolism.
[4] K. Nair,et al. Fasting Increases Human Skeletal Muscle Net Phenylalanine Release and This Is Associated with Decreased mTOR Signaling , 2014, PloS one.
[5] Zaki K Hassan-Smith,et al. 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess , 2014, Proceedings of the National Academy of Sciences.
[6] A. Schols,et al. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. , 2013, The international journal of biochemistry & cell biology.
[7] M. Párraga,et al. Effect of normobaric hypoxia on the testis in a murine model , 2013, Andrologia.
[8] F. Hoffmann,et al. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo. , 2013, Molecular endocrinology.
[9] M. Sandri,et al. Mechanisms regulating skeletal muscle growth and atrophy , 2013, The FEBS journal.
[10] W. Lamers,et al. Distinct responses of protein turnover regulatory pathways in hypoxia- and semistarvation-induced muscle atrophy. , 2013, American journal of physiology. Lung cellular and molecular physiology.
[11] C. Gondro,et al. Impact of fasting on the rhythmic expression of myogenic and metabolic factors in skeletal muscle of adult mice. , 2013, American journal of physiology. Cell physiology.
[12] M. Sandri,et al. Cellular and molecular mechanisms of muscle atrophy , 2013, Disease Models & Mechanisms.
[13] Shakir Ali,et al. Chronic hypobaric hypoxia mediated skeletal muscle atrophy: role of ubiquitin–proteasome pathway and calpains , 2012, Molecular and Cellular Biochemistry.
[14] F. Costes,et al. Hypoxia and muscle maintenance regulation: implications for chronic respiratory disease , 2011, Current opinion in clinical nutrition and metabolic care.
[15] I. Simpson,et al. REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade. , 2011, Biochemical and biophysical research communications.
[16] R. Hoffmann,et al. Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells , 2011, European Respiratory Journal.
[17] S. Matsuyama,et al. Glucocorticoid Elevation of Dexamethasone-induced Gene 2 (Dig2/RTP801/REDD1) Protein Mediates Autophagy in Lymphocytes* , 2011, The Journal of Biological Chemistry.
[18] Keiichi Fukuda,et al. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. , 2011, Cell metabolism.
[19] D. Allen,et al. Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli , 2011, Molecular and Cellular Endocrinology.
[20] M. Shibamori,et al. DNA binding - dependent glucocorticoid receptor activity promotes adipogenesis via krüppel-like factor 15 gene expression , 2010, Laboratory Investigation.
[21] J. Cidlowski,et al. Phosphatidylinositol 3-kinase interacts with the glucocorticoid receptor upon TLR2 activation , 2009, Journal of cellular and molecular medicine.
[22] F. Maltais,et al. Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD , 2010, Thorax.
[23] S. Rothman. How is the balance between protein synthesis and degradation achieved? , 2010, Theoretical Biology and Medical Modelling.
[24] M. Sandri. Autophagy in skeletal muscle , 2010, FEBS letters.
[25] Kathryn G. Foster,et al. Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony* , 2010, The Journal of Biological Chemistry.
[26] R. Blitzer,et al. REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss. , 2010, Endocrinology.
[27] J. Ruijter,et al. Glutamine Synthetase in Muscle Is Required for Glutamine Production during Fasting and Extrahepatic Ammonia Detoxification* , 2010, The Journal of Biological Chemistry.
[28] Philippe Lambin,et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. , 2010, The Journal of clinical investigation.
[29] D. Fingar,et al. mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action* , 2009, The Journal of Biological Chemistry.
[30] W. Mitch,et al. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. , 2009, The Journal of clinical investigation.
[31] P. Walsh,et al. Identification of two glucocorticoid response elements in the promoter region of the ubiquitous isoform of glutamine synthetase in gulf toadfish, Opsanus beta. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[32] Sierra M. Smith. FoxO1 induces apoptosis in skeletal myotubes , 2009 .
[33] F. Buttgereit,et al. Genomic and nongenomic effects of glucocorticoids , 2008, Nature Clinical Practice Rheumatology.
[34] D. Sgroi,et al. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. , 2008, Genes & development.
[35] A. Russell,et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[36] D. Attaix,et al. Myostatin Gene Deletion Prevents Glucocorticoid- Induced Muscle Atrophy , 2022 .
[37] L. Ellisen,et al. Dexamethasone Represses Signaling through the Mammalian Target of Rapamycin in Muscle Cells by Enhancing Expression of REDD1* , 2006, Journal of Biological Chemistry.
[38] C. Proud,et al. The mTOR pathway in the control of protein synthesis. , 2006, Physiology.
[39] M. Decramer,et al. Systemic effects of COPD. , 2005, Respiratory medicine.
[40] D. Glass,et al. Skeletal muscle hypertrophy and atrophy signaling pathways. , 2005, The international journal of biochemistry & cell biology.
[41] H. Esumi,et al. Involvement of Transforming Growth Factor-β1 Signaling in Hypoxia-induced Tolerance to Glucose Starvation* , 2005, Journal of Biological Chemistry.
[42] M. Leonard,et al. Potentiation of Glucocorticoid Activity in Hypoxia through Induction of the Glucocorticoid Receptor1 , 2005, The Journal of Immunology.
[43] Marco Sandri,et al. Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.
[44] J. Jorcano,et al. Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway. , 2004, Molecular endocrinology.
[45] M. Engelen,et al. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[46] A. Klippel,et al. Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4 , 2003, Oncogene.
[47] Hiroshi Nakamura,et al. Role of the Glucocorticoid Receptor for Regulation of Hypoxia-dependent Gene Expression* , 2003, Journal of Biological Chemistry.
[48] S. Bhasin,et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. , 2003, American journal of physiology. Endocrinology and metabolism.
[49] S. Israels,et al. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF , 2003, Oncogene.
[50] A. Goldberg,et al. Patterns of gene expression in atrophying skeletal muscles: response to food deprivation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] J. Blenis,et al. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. , 2002, Molecular cell.
[52] H. van Essen,et al. Pharmacokinetic advantage of intrapericardially applied substances in the rat. , 2002, The Journal of pharmacology and experimental therapeutics.
[53] T. Yoneda,et al. Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease. , 2001, Nutrition.
[54] D. Giussani,et al. Plasma Adrenocorticotropin and Cortisol Concentrations during Acute Hypoxemia after a Reversible Period of Adverse Intrauterine Conditions in the Ovine Fetus During Late Gestation**This work was supported by the British Heart Foundation. , 2001, Endocrinology.
[55] R. Casaburi. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. , 1999, Medicine and science in sports and exercise.
[56] D. Giussani,et al. Plasma adrenocorticotropin and cortisol concentrations during acute hypoxemia after a reversible period of adverse intrauterine conditions in the ovine fetus during late gestation. , 2001, Endocrinology.
[57] E. Wouters,et al. Nutrition and metabolism in COPD. , 2000, Chest.
[58] J. Haspel,et al. Selective expression of Cre recombinase in skeletal muscle fibers , 2000, Genesis.
[59] O. Kretz,et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety , 1999, Nature Genetics.
[60] E. Wouters,et al. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function , 1998, European Journal of Clinical Nutrition.
[61] F. Dela,et al. The effect of altitude hypoxia on glucose homeostasis in men , 1997, The Journal of physiology.
[62] P. Macklem,et al. Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[63] A. Goldberg,et al. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. , 1995, The Biochemical journal.
[64] A. Goldberg,et al. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. , 1993, The American journal of physiology.
[65] S. Mason,et al. Fluorimetric detection of serum corticosterone using high-performance liquid chromatography. , 1992, Journal of chromatography.
[66] M. Sporn,et al. Hypoxia upregulates the synthesis of tgf-β1 by human dermal fibroblasts , 1991 .
[67] M. Sporn,et al. Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. , 1991, The Journal of investigative dermatology.
[68] B. T. Jackson,et al. Adrenal secretion of glucocorticoids during hypoxemia in fetal sheep. , 1989, Endocrinology.
[69] P. Gluckman,et al. Insulin-like growth factor-1 (IGF-1) in mice reduces weight loss during starvation. , 1989, Endocrinology.
[70] E. Hartsook,et al. Effects of fasting on muscle protein turnover, the composition of weight loss, and energy balance of obese and nonobese Zucker rats. , 1982, The Journal of nutrition.
[71] S. Gruenau,et al. Cross-adaptive effects of cold, hypoxia, or physical training on decompression sickness in mice. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.
[72] R. N. Hardy,et al. Adrenal and pancreatic endocrine responses to hypoxia in the conscious calf. , 1976, The Journal of physiology.
[73] F. Moncloa,et al. ENDOCRINE STUDIES AT HIGH ALTITUDE , 1968 .